Tandem Diabetes Care | Ventes



Sales Changement Date
Abbott USD 10.97B 370M 2024-12
Align Technology USD 995.22M 17.35M 2024-12
AtriCure USD 124.28M 8.37M 2024-12
Baxter International USD 2.75B 54M 2024-12
Becton, Dickinson and Co. USD 5.17B 269M 2024-12
Boston Scientific USD 4.56B 352M 2024-12
Cooper Companies USD 964.7M 53.7M 2025-01
Dexcom USD 1.11B 119.3M 2024-12
Edwards Lifesciences USD 1.39B 31.4M 2024-12
Eli Lilly USD 13.53B 2.09B 2024-12
Globus Medical USD 657.29M 31.59M 2024-12
ICU Medical USD 629.8M 40.67M 2024-12
Insulet USD 597.5M 53.6M 2024-12
Integra LifeSciences USD 442.65M 61.81M 2024-12
Intuitive Surgical USD 2.41B 370M 2024-12
J&J USD 22.52B 49M 2024-12
Masimo USD 600.7M 96.1M 2024-12
Medtronic USD 8.29B 111M 2025-01
Merit Medical Systems USD 355.16M 15.31M 2024-12
Roche Holding CHF 31.64B 883M 2024-12
Stryker USD 6.44B 942M 2024-12
Tandem Diabetes Care USD 282.65M 38.68M 2024-12
Teleflex USD 795.41M 31.03M 2024-12
Zimmer Biomet Holdings USD 2.02B 199M 2024-12



Tandem Diabetes Care Ventes - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Mar 2025.